Skip to content

Underprescribing in Geriatric Patients: a Prevalence Study and Analysis of Factors Contributing to Potential Prescription Omissions (Under-PRES)

Underprescribing in Geriatric Patients: a Prevalence Study and Analysis of Factors Contributing to Potential Prescription Omissions (Under-PRES)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06904638
Acronym
Under-PRES
Enrollment
374
Registered
2025-04-01
Start date
2024-06-20
Completion date
2026-12-31
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Older People

Keywords

underprescription, START criteria, potential prescriptive omissions

Brief summary

This observational study will determine the prevalence of underprescription in a cohort of elderly patients, recruited at the time of an outpatient geriatric visit, or hospitalized, upon admission to a geriatric ward.

Detailed description

Polypharmacy in older patients is associated with both inappropriate drug prescribing and underprescription or omission of appropriate medications. Potential prescriptive omission (PPO), defined as the underprescription of potentially beneficial drugs, is increasing across all care settings and is associated with adverse clinical outcomes. However, in some cases, PPO may represent a legitimate medical decision. The aim of this study is to investigate the phenomenon of underprescription by differentiating between justified and inappropriate potential prescriptive omissions (PPOs) in elderly patients in both hospital and outpatient settings, using the Screening Tool to Alert to Right Treatment (START) criteria, version 3.

Interventions

None listed

Sponsors

Istituto Nazionale di Ricovero e Cura per Anziani
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Geriatric ward admission or outpatient geriatric appointment * Capacity to provide informed consent by the patient or legal guardian

Exclusion criteria

* Limited life expectancy as measured by the Clinical Frailty Scale (CFS) \>8

Design outcomes

Primary

MeasureTime frameDescription
Rate of potential prescription omissions (PPOs)at baseline and 3 months laterPrevalence of potential prescription omissions (PPOs) will be evaluated by Screening Tool to Alert doctors to Right Treatment (START) criteria version 3 in aged patients enrolled on admission to geriatric departments of participating centers or during geriatric outpatient clinic visits

Secondary

MeasureTime frameDescription
Characterisation of the potential prescription omissions (PPOs)at baseline and 3 months laterThe reasons for underprescription will be investigated to differentiate between justified and inappropriate potential prescriptive omissions (PPOs). Patients and/or their family members and/or the general practitioner will be interviewed to assess the potential reasons related to underprescription.

Countries

Italy

Contacts

Primary ContactAnna Rita Bonfigli
a.bonfigli@inrca.it0718003719

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026